Takuya Miyagawa

16PUBLICATIONS
100CO-AUTHORS
NanomedicinePredictive and prognostic markersTumour immunologyPeripheral nervous systemMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Mar 03, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Kohei Oashi, Dai Ogata, Masayuki Yokoyama

|Feb 13, 2026
Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma.

Kenta Oka, Takuya Miyagawa, Hiromichi Morita

|Oct 22, 2025
Serum Nectin-4 as a Potential Prognostic Biomarker for Extramammary Paget Disease.

Hiromichi Morita, Takuya Miyagawa, Kenta Oka

|Jun 13, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025.

Satoshi Fukushima, Takamichi Ito, Jun Asai

|Apr 04, 2025
Adjuvant Anti-PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients.

Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki

Pageof 3

Frequent Collaborators

7 joint publications

Kenjiro Namikawa

5 joint publications

Eiji Nakano

5 joint publications

Yasuhiro Nakamura

5 joint publications

Dai Ogata